Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma

NCT00752063 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma
Metastatic Hepatocellular Carcinoma

Interventions

DRUG: Sorafenib with Capecitabine and Oxaliplatin

Sponsor

The University of Hong Kong